Pfizer-BioNTech COVID-19-Impfstoff zeigt bei Kindern im Alter von 6 Monaten bis unter 5 Jahren nach drei Dosen starke Immunantworten, hohe Wirksamkeit und vorteilhaftes Sicherheitsprofil
May 23, 2022 06:45 ET
|
BioNTech SE
Basierend auf den ersten Studiendaten erfüllen drei Dosen des Pfizer-BioNTech COVID-19-Impfstoffs alle für die US-Notfallzulassung notwendigen Immunobridging-Kriterien (Vergleich der...
BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of BHVN and Encourages Investors to Contact the Firm
May 10, 2022 16:58 ET
|
Bragar Eagel & Squire
NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Dyadic Announces Successful Toxicology Data Published in “Toxicologic Pathology”
May 09, 2022 08:30 ET
|
Dyadic International, Inc.
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile and lasting immunogenic response from Dyadic’s DYAI-100,...
Pfizer und BioNTech veröffentlichen Daten zu starker Immunantwort nach Auffrischungsimpfung mit dem COVID-19-Impfstoff bei Kindern im Alter von 5 bis 11 Jahren
April 14, 2022 06:45 ET
|
BioNTech SE
Daten einer Subanalyse mit 30 Seren aus einer klinischen Phase-2/3-Studie mit Kindern im Alter von 5 bis 11 Jahren zeigen einen 36-fachen Anstieg der neutralisierenden Antikörpertiter gegen die...
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
April 14, 2022 06:45 ET
|
BioNTech SE
Data from a subanalysis of 30 sera from a Phase 2/3 clinical trial of children 5 through 11 years of age show a 36-fold increase in SARS-CoV-2 Omicron neutralizing titers following a booster (third)...
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
April 13, 2022 08:52 ET
|
Dyadic International, Inc.
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2 antigenFunding earmarked to support Phase 1 and 2 clinical trials of Epygen’s...
FXCM February Single Share & Stock Baskets Report
March 28, 2022 04:00 ET
|
FXCM Group
LONDON, March 28, 2022 (GLOBE NEWSWIRE) -- FXCM Group, LLC (“FXCM Group’ or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading, cryptocurrencies and related...
FXCM February Single Share & Stock Baskets Report
March 28, 2022 04:00 ET
|
FXCM Group
SYDNEY, Australia, March 28, 2022 (GLOBE NEWSWIRE) -- FXCM Group, LLC (“FXCM Group’ or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading, cryptocurrencies...
FXCM February Single Share & Stock Baskets Report
March 24, 2022 10:07 ET
|
FXCM Group
JOHANNESBURG, South Africa, March 24, 2022 (GLOBE NEWSWIRE) -- FXCM Group, LLC (“FXCM Group’ or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading,...
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
March 15, 2022 18:00 ET
|
BioNTech SE
Submission based on real-world safety and efficacy data from Israel Data showed rates of confirmed infections were 2 times lower and rates of severe illness were 4 times lower among individuals who...